Glucosephosphate Dehydrogenase Deficiency
Recent clinical, regulatory, research and industry developments relating to this disease.
The global role of G6PD in infection and immunity.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Glucosephosphate Dehydrogenase1
- Glucosephosphate Dehydrogenase Deficiency1
Leading journals1
- Frontiers in immunology1
Leading researchers4
- Francis RO1
- Karafin MS1
- Shah SS1
- Stone EF1
Affiliations (unnormalised)2
- Columbia University1
- Department of Pathology and Laboratory Medicine1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Disease biology
Proteins whose encoding gene is associated with this disease, reached through the canonical gene→disease graph. Number shows the gene's association score.
Reference
Authoritative identity, definition & identifiers.
A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.